| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.004 | 1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |